The Roundtable Responds to Senate Finance Committee RFI on Policy Options to Lower Drug Prices

On June 16, 2026, the Senate Finance Committee minority staff announced a Request for Information (RFI) titled “Commonsense Policy Options to Lower Drug Prices.” The RFI comes after Ranking Member Wyden (D-OR), along with Senators Cortez Masto (D-NV), Welch (D-VT), and Gallego (D-AZ), released a Dear Colleague letter to the Senate Democratic caucus on February 3, 2026. That letter outlined a three-pronged plan to build on the Inflation Reduction Act and further lower prescription drug prices. Several other Democratic senators, including Kelly (D-AZ), Baldwin (D-WI), Hassan (D-NH), Merkley (D-OR), Van Hollen (D-MD), Duckworth (D-IL), and Blumenthal (D-CT), have since joined the effort.

Following the release of the Dear Colleague letter, Finance Committee minority staff held listening sessions with more than 70 external organizations, including the Roundtable. The RFI builds on those conversations, seeking detailed feedback on policy options to lower manufacturer drug prices, reduce patient out-of-pocket costs, and support continued biopharmaceutical innovation. Read the full letter here.